Analysis of 21-deoxycortisol, a marker of congenital adrenal hyperplasia, in blood by atmospheric pressure chemical ionization and electrospray ionization using multiple reaction monitoring

被引:17
作者
Cristoni, S
Cuccato, D
Sciannamblo, M
Bernardi, LR
Biunno, I
Gerthoux, P
Russo, G
Weber, G
Mora, S
机构
[1] Univ Milan, CISI, Ctr Biomol Interdisciplinary Studies & Ind Applic, I-20090 Milan, Italy
[2] San Raffaele Sci Inst, Lab Pediat Endocrinol, I-20132 Milan, Italy
[3] San Raffaele Sci Inst, Dept Pediat, I-20132 Milan, Italy
[4] CNR, ITB, I-20090 Milan, Italy
[5] Univ Milano Bicocca, Hosp Desio, Univ Dept Lab Med, I-20033 Milan, Italy
关键词
D O I
10.1002/rcm.1284
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder mainly caused by 21-hydroxylase deficit (21-OHD). Deletions or mutations of the CYP21 gene induce the impairment of glucocorticoid and mineralcorticoid synthesis. 17-Hydroxyprogesterone (17-OHP) is the hormonal marker in patients, but not in the heterozygous subjects. Excess 17-OHP is hydroxylated into 21-deoxycortisol (21-DF), and therefore 21-DF can be used as a specific marker for diagnosis of heterozygous individuals. We report an analytical method for analysis of 21-DF in blood samples using electrospray (ESI) and atmospheric pressure chemical ionization (APCI), showing that ESI is very sensitive for the analysis of this marker molecule. The multiple reaction monitoring (MRM) approach was used to increase the specificity and the sensitivity of the method. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 33 条
[1]  
[Anonymous], PEDIAT ENDOCRINOLOGY
[2]  
Antignac JP, 2000, RAPID COMMUN MASS SP, V14, P33, DOI 10.1002/(SICI)1097-0231(20000115)14:1<33::AID-RCM829>3.3.CO
[3]  
2-I
[4]   MONITORING TREATMENT IN CONGENITAL ADRENAL-HYPERPLASIA [J].
APPAN, S ;
HINDMARSH, PC ;
BROOK, CGD .
ARCHIVES OF DISEASE IN CHILDHOOD, 1989, 64 (09) :1235-1239
[5]   Separation and detection of neuroactive steroids from biological matrices [J].
Appelblad, P ;
Irgum, K .
JOURNAL OF CHROMATOGRAPHY A, 2002, 955 (02) :151-182
[6]   GROWTH IN CONGENITAL ADRENAL HYPERPLASIA [J].
BERGSTRAND, CG .
ACTA PAEDIATRICA SCANDINAVICA, 1966, 55 (05) :463-+
[7]   THE MANAGEMENT OF CLASSICAL CONGENITAL ADRENAL-HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY [J].
BROOK, CGD .
CLINICAL ENDOCRINOLOGY, 1990, 33 (04) :559-567
[8]   The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens [J].
Caulfield, MP ;
Lynn, T ;
Gottschalk, ME ;
Jones, KL ;
Taylor, NF ;
Malunowicz, EM ;
Shackleton, CHL ;
Reitz, RE ;
Fisher, DA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3682-3690
[9]   STEROID 21-HYDROXYLATION BY HUMAN PREOVULATORY FOLLICLES FROM STIMULATED CYCLES - A MASS-SPECTROMETRIC STUDY OF DEOXYCORTICOSTERONE, 21-HYDROXYPREGNENOLONE AND 11-DEOXYCORTISOL IN FOLLICULAR-FLUID [J].
DEHENNIN, L ;
NAHOUL, K ;
SCHOLLER, R .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1987, 26 (03) :337-343
[10]   COMPARISON OF BASAL AND ADRENOCORTICOTROPIN-STIMULATED PLASMA 21-DEOXYCORTISOL AND 17-HYDROXYPROGESTERONE VALUES AS BIOLOGICAL MARKERS OF LATE-ONSET ADRENAL-HYPERPLASIA [J].
FIET, J ;
GUEUX, B ;
GOURMELEN, M ;
KUTTENN, F ;
VEXIAU, P ;
COUILLIN, P ;
PHAMHUUTRUNG, MT ;
VILLETTE, JM ;
RAUXDEMAY, MC ;
GALONS, H ;
JULIEN, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (04) :659-667